METAGENOMI INC. - COM
2.0700
29-November-24 12:45:00
15 minutes delayed
Stocks
+0.0500
+2.48%
Today's range
1.9700 - 2.1100
ISIN
N/A
Source
NASDAQ
-
Metagenomi Reports Business Updates and Third Quarter 2024 Financial Results
13 Nov 2024 15:05:00 By Nasdaq GlobeNewswire
-
05 Nov 2024 15:05:00 By Nasdaq GlobeNewswire
-
24 Oct 2024 07:04:50 By Nasdaq GlobeNewswire
-
14 Oct 2024 19:58:21 By Nasdaq GlobeNewswire
-
Metagenomi to Present at Chardan's 8th Annual Genetic Medicines Conference
19 Sep 2024 18:15:11 By Nasdaq GlobeNewswire
-
03 Sep 2024 15:05:00 By Nasdaq GlobeNewswire
-
29 Aug 2024 18:32:08 By Nasdaq GlobeNewswire
-
Metagenomi to Participate in Upcoming Investor Conferences
28 Aug 2024 17:10:18 By Nasdaq GlobeNewswire
-
Metagenomi Reports Business Updates and Second Quarter 2024 Financial Results
14 Aug 2024 07:05:00 By Nasdaq GlobeNewswire
-
Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference
29 May 2024 15:00:00 By Nasdaq GlobeNewswire
-
Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results
14 May 2024 15:05:00 By Nasdaq GlobeNewswire
-
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
01 May 2024 15:00:00 By Nasdaq GlobeNewswire
-
Metagenomi to Present at Upcoming Scientific Meetings
08 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
Metagenomi Reports Business Updates and Full Year 2023 Financial Results
27 Mar 2024 08:16:21 By Nasdaq GlobeNewswire
-
Metagenomi to Participate in the 44th Annual Cowen Healthcare Conference
29 Feb 2024 15:30:00 By Nasdaq GlobeNewswire
-
Metagenomi Announces Closing of Initial Public Offering
13 Feb 2024 15:35:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >